StockNews.AI
CDLX
StockNews.AI
176 days

Class Action Filed Against Cardlytics, Inc. (CDLX) Seeking Recovery for Investors - Contact The Gross Law Firm

1. Class action lawsuit targets CDLX for alleged misleading disclosures. Allegations involve false revenue growth claims. 2. Complaint cites under-delivery of ad budgets due to changes in Ads Decision Engine. Risk of slower revenue growth noted. 3. Class period spans from March 14, 2024 to August 7, 2024. Lead plaintiff registration deadline is March 25, 2025. 4. Investors are urged to join the lawsuit for potential recovery. Legal action may impact CDLX's reputation.

4m saved
Insight
Article

FAQ

Why Bearish?

The legal action introduces risks of financial penalties and reputational damage. Historical similar cases, like class actions against tech firms, have often led to short-term share price drops and lingering uncertainty.

How important is it?

The lawsuit alleges material misrepresentations affecting key revenue metrics, which poses significant long-term risks. Such legal proceedings can result in substantial financial liabilities and prolonged management distraction, influencing investor decisions.

Why Long Term?

Litigation could lead to prolonged uncertainty over CDLX’s fundamentals and future revenue prospects. Past lawsuits in similar sectors have had lasting impacts on investor confidence.

Related Companies

NEW YORK, Feb. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cardlytics-loss-submission-form/?id=131198&from=4 CLASS PERIOD: March 14, 2024 to August 7, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) increasing consumer engagement led to an increase in consumer incentives; (2) the Company could not increase its billings commensurate with the increased consumer engagement; (3) as a result, there was a significant risk that its revenue growth would slow or decline; (4) the changes to Ads Decision Engine, which led to increased consumer engagement, led to the "under-delivery" of budgets and customers billing estimates; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. DEADLINE: March 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/cardlytics-loss-submission-form/?id=131198&from=4 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CDLX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 25, 2025. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: [email protected]Phone: (646) 453-8903 SOURCE The Gross Law Firm

Related News